Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
European Equities Traded in US as ADRs Fall in Thursday Trading

European Equities Traded in US as ADRs Fall in Thursday Trading

MT newswireMT newswire2026/10/08 15:05

11:05 AM EDT, 10/08/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts fell late Thursday morning with the S&P Europe Select ADR Index declining 0.3% to 1,870.68. From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which increased 3.1% and 3%, respectively. They were followed by medical device maker EDAP TMS (FOCL) and brewing company Anheuser-Busch InBev (BUD), which advanced 2.9% and 2.8%, respectively. The decliners from continental Europe were led by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which shed 14% and 3.7%, respectively. They were followed by telecommunications company Nokia (NOK) and biotech firm BioNTech (BNTX), which dropped 3.2% and 3%, respectively. The gainers from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which rose 3.7% and 3.4%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and educational publisher Pearson (PSO), which were up 3.2% and 2%, respectively. The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 7.7% and 5.5%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biotech firm Autolus Therapeutics (AUTL), which dropped 5% and 3.6%, respectively.

11:05 AM EDT, 10/08/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts fell late Thursday morning with the S&P Europe Select ADR Index declining 0.3% to 1,870.68. From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which increased 3.1% and 3%, respectively. They were followed by medical device maker EDAP TMS (FOCL) and brewing company Anheuser-Busch InBev (BUD), which advanced 2.9% and 2.8%, respectively. The decliners from continental Europe were led by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which shed 14% and 3.7%, respectively. They were followed by telecommunications company Nokia (NOK) and biotech firm BioNTech (BNTX), which dropped 3.2% and 3%, respectively. The gainers from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which rose 3.7% and 3.4%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and educational publisher Pearson (PSO), which were up 3.2% and 2%, respectively. The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 7.7% and 5.5%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biotech firm Autolus Therapeutics (AUTL), which dropped 5% and 3.6%, respectively.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Morningstar expects Woodside's revenue growth will outpace global peers by the end of this decade

On October 9, Morningstar predicted that the revenue of Australian oil and gas producer Woodside Energy (WDS.AX) will grow by over 30% by 2030, outpacing any of its international peers. Woodside Energy’s share price dropped by 0.6% on the day to 32.12 AUD, after surging 2.6% in the previous trading session. The stock is poised to end a three-week losing streak, with oil prices rising due to escalating tensions in the Middle East, and is set for a 2.8% weekly gain O/R. Morningstar expects Woodside’s revenue to increase as major new projects come online, and forecasts free cash flow to exceed 7 billion USD after 2030, reflecting a 300% rise from 2025. The report added that market sentiment remains bearish, with the current share price below its estimated fair value of 44.00 AUD. Year-to-date, Woodside’s share price has risen 36.2%, while Santos shares are up 41.3%. (For the convenience of non-English speakers, Reuters has automated the translation of its reports into several languages. Since automated translations may be inaccurate or lack required context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for the convenience of readers. Reuters accepts no liability for any loss or damage arising from your use of automated translation functions.)

路透社•2026/10/09 02:16

Star analyst Ives: Bullish on Apple (AAPL.US) up to $400, AI strategy may increase valuation by $75 per share

Ives has given Apple stock an "outperform" rating, with a target price of $400.

智通财经•2026/10/09 02:01

New York gold prices rose on the 8th

新浪财经•2026/10/09 01:36